Does the media refer more to IRTC or SOLV?

In the previous week, iRhythm Technologies had 3 more articles in the media than Solventum. MarketBeat recorded 6 mentions for iRhythm Technologies and 3 mentions for Solventum. iRhythm Technologies' average media sentiment score of 0.65 beat Solventum's score of 0.25 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solventum 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, SNN or IRTC?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Smith & Nephew SNATS $6.16B 2.04 $625M N/A N/A iRhythm Technologies $747.14M 4.84 -$44.55M -$0.86 N/A

Does the media refer more to IRTC or PEN?

In the previous week, iRhythm Technologies had 4 more articles in the media than Penumbra. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 0.68 beat iRhythm Technologies' score of 0.65 indicating that Penumbra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or GKOS?

In the previous week, iRhythm Technologies and iRhythm Technologies both had 6 articles in the media. Glaukos' average media sentiment score of 0.99 beat iRhythm Technologies' score of 0.65 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Glaukos 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, IRTC or LQDA?

iRhythm Technologies has higher revenue and earnings than Liquidia. iRhythm Technologies is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 4.84 -$44.55M -$0.86 N/A Liquidia $158.32M 41.59 -$68.92M $0.14 528.86

Does the media favor IRTC or LQDA?

In the previous week, Liquidia had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 14 mentions for Liquidia and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.65 beat Liquidia's score of 0.53 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Liquidia 5 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

iRhythm Technologies (IRTC) Competitors

$110.12 +5.43 (+5.19%)

As of 04:00 PM Eastern

Compare

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

Should you buy iRhythm Technologies stock or one of its competitors? MarketBeat compares iRhythm Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iRhythm Technologies include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Glaukos (GKOS), and Liquidia (LQDA). These companies are all part of the "medical equipment" industry.

How does iRhythm Technologies compare to Solventum?

iRhythm Technologies (NASDAQ:IRTC) and Solventum (NYSE:SOLV) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Solventum has a net margin of 17.33% compared to iRhythm Technologies' net margin of -3.53%. Solventum's return on equity of 23.51% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Solventum	17.33%	23.51%	7.63%

In the previous week, iRhythm Technologies had 3 more articles in the media than Solventum. MarketBeat recorded 6 mentions for iRhythm Technologies and 3 mentions for Solventum. iRhythm Technologies' average media sentiment score of 0.65 beat Solventum's score of 0.25 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Solventum	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies currently has a consensus target price of $187.38, suggesting a potential upside of 70.16%. Solventum has a consensus target price of $84.25, suggesting a potential upside of 13.64%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Solventum has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market.

Solventum has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.84	-$44.55M	-$0.86	N/A
Solventum	$8.33B	1.54	$1.56B	$8.16	9.09

Summary

iRhythm Technologies beats Solventum on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Smith & Nephew SNATS (NYSE:SNN) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

In the previous week, iRhythm Technologies had 6 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 6 mentions for iRhythm Technologies and 0 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 0.65 beat Smith & Nephew SNATS's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Smith & Nephew SNATS	Neutral
iRhythm Technologies	Positive

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew SNATS	N/A	N/A	N/A
iRhythm Technologies	-3.53%	-10.26%	-1.39%

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew SNATS	$6.16B	2.04	$625M	N/A	N/A
iRhythm Technologies	$747.14M	4.84	-$44.55M	-$0.86	N/A

Smith & Nephew SNATS presently has a consensus target price of $30.93, suggesting a potential upside of 4.41%. iRhythm Technologies has a consensus target price of $187.38, suggesting a potential upside of 70.16%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts clearly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

25.6% of Smith & Nephew SNATS shares are held by institutional investors. 1.0% of Smith & Nephew SNATS shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Smith & Nephew SNATS has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Summary

iRhythm Technologies beats Smith & Nephew SNATS on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Penumbra?

iRhythm Technologies (NASDAQ:IRTC) and Penumbra (NYSE:PEN) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends and risk.

Penumbra has a net margin of 11.76% compared to iRhythm Technologies' net margin of -3.53%. Penumbra's return on equity of 10.87% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Penumbra	11.76%	10.87%	8.45%

iRhythm Technologies currently has a consensus target price of $187.38, suggesting a potential upside of 70.16%. Penumbra has a consensus target price of $361.33, suggesting a potential upside of 13.60%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.84	-$44.55M	-$0.86	N/A
Penumbra	$1.40B	8.91	$177.69M	$4.34	73.29

88.9% of Penumbra shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 2.9% of Penumbra shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

iRhythm Technologies has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Penumbra has a beta of 0.71, indicating that its share price is 29% less volatile than the broader market.

In the previous week, iRhythm Technologies had 4 more articles in the media than Penumbra. MarketBeat recorded 6 mentions for iRhythm Technologies and 2 mentions for Penumbra. Penumbra's average media sentiment score of 0.68 beat iRhythm Technologies' score of 0.65 indicating that Penumbra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Penumbra beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Glaukos?

iRhythm Technologies (NASDAQ:IRTC) and Glaukos (NYSE:GKOS) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

iRhythm Technologies has higher revenue and earnings than Glaukos. iRhythm Technologies is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.84	-$44.55M	-$0.86	N/A
Glaukos	$507.44M	15.64	-$187.69M	-$3.28	N/A

In the previous week, iRhythm Technologies and iRhythm Technologies both had 6 articles in the media. Glaukos' average media sentiment score of 0.99 beat iRhythm Technologies' score of 0.65 indicating that Glaukos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Glaukos	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Glaukos has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

iRhythm Technologies has a net margin of -3.53% compared to Glaukos' net margin of -34.34%. Glaukos' return on equity of -6.92% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Glaukos	-34.34%	-6.92%	-5.25%

99.0% of Glaukos shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 5.9% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

iRhythm Technologies presently has a consensus price target of $187.38, indicating a potential upside of 70.16%. Glaukos has a consensus price target of $149.17, indicating a potential upside of 10.42%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe iRhythm Technologies is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Glaukos	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

Summary

iRhythm Technologies beats Glaukos on 9 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Liquidia?

iRhythm Technologies (NASDAQ:IRTC) and Liquidia (NASDAQ:LQDA) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, earnings, dividends, risk, analyst recommendations and institutional ownership.

Liquidia has a net margin of 7.74% compared to iRhythm Technologies' net margin of -3.53%. Liquidia's return on equity of 46.82% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Liquidia	7.74%	46.82%	7.06%

iRhythm Technologies presently has a consensus target price of $187.38, indicating a potential upside of 70.16%. Liquidia has a consensus target price of $67.43, indicating a potential downside of 8.93%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, research analysts clearly believe iRhythm Technologies is more favorable than Liquidia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Liquidia	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	3 Strong Buy rating(s)	2.90

In the previous week, Liquidia had 8 more articles in the media than iRhythm Technologies. MarketBeat recorded 14 mentions for Liquidia and 6 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.65 beat Liquidia's score of 0.53 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Liquidia	5 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

64.5% of Liquidia shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by insiders. Comparatively, 25.6% of Liquidia shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

iRhythm Technologies has a beta of 1.27, suggesting that its stock price is 27% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market.

iRhythm Technologies has higher revenue and earnings than Liquidia. iRhythm Technologies is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	4.84	-$44.55M	-$0.86	N/A
Liquidia	$158.32M	41.59	-$68.92M	$0.14	528.86

Summary

Liquidia beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.44B	$1.54B	$6.45B	$12.39B
Dividend Yield	N/A	N/A	2.69%	5.83%
P/E Ratio	-128.05	50.62	21.07	22.20
Price / Sales	4.84	7.34	530.36	110.15
Price / Cash	N/A	23.50	44.82	54.51
Price / Book	23.23	5.16	10.79	6.50
Net Income	-$44.55M	-$54.76M	$3.56B	$336.88M
7 Day Performance	1.18%	-1.75%	1.67%	-0.22%
1 Month Performance	-5.53%	-3.64%	0.43%	0.77%
1 Year Performance	-27.05%	-1.78%	32.84%	31.57%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	4.185 of 5 stars	$110.12 +5.2%	$187.38 +70.2%	-28.2%	$3.44B	$747.14M	N/A	2,400	Analyst Forecast
SOLV Solventum	3.4852 of 5 stars	$75.72 +0.4%	$84.25 +11.3%	-0.1%	$13.06B	$8.33B	9.28	20,000
SNN Smith & Nephew SNATS	2.0944 of 5 stars	$30.11 +0.1%	$30.93 +2.7%	+2.0%	$12.79B	$6.16B	N/A	16,988
PEN Penumbra	2.5313 of 5 stars	$316.88 -0.1%	$361.33 +14.0%	+23.3%	$12.48B	$1.40B	73.01	4,700
GKOS Glaukos	3.4509 of 5 stars	$130.88 +0.1%	$149.17 +14.0%	+30.8%	$7.68B	$507.44M	N/A	1,094	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

How does iRhythm Technologies compare to Solventum?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Glaukos?

Summary

How does iRhythm Technologies compare to Liquidia?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. SOLV, SNN, PEN, GKOS, and LQDA

How does iRhythm Technologies compare to Solventum?

Is IRTC or SOLV more profitable?

Does the media refer more to IRTC or SOLV?

Do analysts recommend IRTC or SOLV?

Which has more volatility & risk, IRTC or SOLV?

Which has better earnings and valuation, IRTC or SOLV?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Does the media prefer SNN or IRTC?

Is SNN or IRTC more profitable?

Which has better valuation & earnings, SNN or IRTC?

Do analysts recommend SNN or IRTC?

Do insiders and institutionals hold more shares of SNN or IRTC?

Which has more volatility & risk, SNN or IRTC?

Summary

How does iRhythm Technologies compare to Penumbra?

Is IRTC or PEN more profitable?

Do analysts rate IRTC or PEN?

Which has preferable valuation and earnings, IRTC or PEN?

Do insiders & institutionals have more ownership in IRTC or PEN?

Which has more volatility & risk, IRTC or PEN?

Does the media refer more to IRTC or PEN?

Summary

How does iRhythm Technologies compare to Glaukos?

Which has preferable valuation & earnings, IRTC or GKOS?

Does the media favor IRTC or GKOS?

Which has more volatility & risk, IRTC or GKOS?

Is IRTC or GKOS more profitable?

Do insiders & institutionals believe in IRTC or GKOS?

Do analysts recommend IRTC or GKOS?

Summary

How does iRhythm Technologies compare to Liquidia?

Is IRTC or LQDA more profitable?

Do analysts prefer IRTC or LQDA?

Does the media favor IRTC or LQDA?

Do institutionals & insiders believe in IRTC or LQDA?

Which has more risk and volatility, IRTC or LQDA?

Which has better earnings & valuation, IRTC or LQDA?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools